| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.1 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.24 | 0.1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |